Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Solomon

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
JAMA|April 6, 1994
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupM J Knapp, D S Knopman, P R Solomon, et al.
International Psychogeriatrics|March 27, 2001
Identifying dementia in the primary care practiceP R Solomon, M Brush, V Calvo, et al.
Neuroscience|January 1, 1989
Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbitsM F Beal, M F Mazurek, D W Ellison, et al.
Annals of the New York Academy of Sciences|September 15, 1995
Structural-functional correlates of neuroprotection in the aging rabbit by a calcium channel blocker. Nimodipine reverses neocortical dendritic atrophy and improves memory retentionR F Mervis, N Kuntz, D Burton, et al.
Behavioral Neuroscience|April 1, 1993
Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamineP R Solomon, M E Groccia-Ellison, D Flynn, et al.
Neurobiology of Aging|September 1, 1995
Nimodipine facilitates retention of the classically conditioned nictitating membrane response in aged rabbits over long retention intervalsP R Solomon, M S Wood, M E Groccia-Ellison, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
JAMA|April 6, 1994
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupM J Knapp, D S Knopman, P R Solomon, et al.
International Psychogeriatrics|March 27, 2001
Identifying dementia in the primary care practiceP R Solomon, M Brush, V Calvo, et al.
Neuroscience|January 1, 1989
Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbitsM F Beal, M F Mazurek, D W Ellison, et al.
Annals of the New York Academy of Sciences|September 15, 1995
Structural-functional correlates of neuroprotection in the aging rabbit by a calcium channel blocker. Nimodipine reverses neocortical dendritic atrophy and improves memory retentionR F Mervis, N Kuntz, D Burton, et al.
Behavioral Neuroscience|April 1, 1993
Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamineP R Solomon, M E Groccia-Ellison, D Flynn, et al.
Neurobiology of Aging|September 1, 1995
Nimodipine facilitates retention of the classically conditioned nictitating membrane response in aged rabbits over long retention intervalsP R Solomon, M S Wood, M E Groccia-Ellison, et al.
Pageof 6